Abilify - Injuries & Lawsuits

Abilify New

Deadline for Abilify Makers Less Than a Month Away

As of April of 2018, the were over 800 lawsuits pending against Otsuka Pharmaceuticals and its U.S. partner, Bristol-Meyer Squibb (BMS) over the psychoactive medication Abilify (aripiprizole).  Plaintiffs allege that the drugmakers failed to warn patients and doctors...

Treating Autism With Abilify: Is It a Good Idea?

In 2009, the FDA approved Abilify (aripiprazole) for treating irritability in autistic children and youth up to age 17. In a press release issued at the time, manufacturer Bristol-Meyers Squibb stated that Abilify – normally used to treat bipolar disorder,...

Abilify Videos

Additional Abilify Issues

To review more information regarding Abilify (including scientific studies, government warnings, recalls and litigation), visit Abilify Info, a comprehensive webpage maintained by the law firm of Levin Papantonio.

Our Purpose

It’s our goal to provide you news regarding prescription drugs and medical devices that have been the subject of recalls and/or national litigation. The information provided within this site is not a substitute for professional medical advice, diagnosis or treatment. If you have concerns after reading this information, you should not stop using your prescription drugs or devices without first talking with your treating physician to discuss the proper treatment plan for you.

The Ring of Fire Network

Drugs Safety News is a product of The Ring of Fire Network. Ring of Fire started as a weekly syndicated radio show in 2004 for the purpose of exposing Wall Street thugs, environmental criminality, corporate media failure, and political back stories that rarely can be found from other sources. Since its formation, The Ring of Fire has expanded into a multi-media network for the latest Progressive news, commentary and analysis

Search Our Site